AMGN Amgen Inc

USD 289.18 0.00 0
Icon

Amgen Inc (AMGN) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 289.18

0.00 (0.00)%

USD 154.98B

2.46M

USD 299.96(+3.73%)

USD 278.09 (-3.83%)

Icon

AMGN

Amgen Inc (USD)
COMMON STOCK | NSD
USD 289.18
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 154.98B

USD 278.09 (-3.83%)

USD 289.18

Amgen Inc (AMGN) Stock Forecast

USD 299.96
(+3.73%)

Based on the Amgen Inc stock forecast from 17 analysts, the average analyst target price for Amgen Inc is USD 299.96 over the next 12 months. Amgen Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Amgen Inc is Slightly Bullish , which is based on 9 positive signals and 4 negative signals. At the last closing, Amgen Inc’s stock price was USD 289.18. Amgen Inc’s stock price has changed by +1.93% over the past week, -5.34% over the past month and +23.76% over the last year.

No recent analyst target price found for Amgen Inc
No recent average analyst rating found for Amgen Inc

Company Overview Amgen Inc

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, pso...Read More

https://www.amgen.com

One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799

26,700

December

USD

USA

Adjusted Closing Price for Amgen Inc (AMGN)

Loading...

Unadjusted Closing Price for Amgen Inc (AMGN)

Loading...

Share Trading Volume for Amgen Inc Shares

Loading...

Compare Performance of Amgen Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AMGN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Amgen Inc (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AZN
AstraZeneca PLC ADR 0.00 (0.00%) USD204.10B 34.65 16.64

ETFs Containing AMGN

Symbol Name AMGN's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Amgen Inc (AMGN) Stock

Based on ratings from 17 analysts Amgen Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 14 buy, sell and 11 hold ratings.

AMGN stock's dividend yield is 3.11%. Our analysis grades AMGN stock's dividend yield at F. This means that AMGN stock's dividend yield is above 33% of the stocks in the Drug Manufacturers - General sector in the NSD exchange. Based on this AMGN may be a poor dividend stock for its sector.

Based on targets from 17 analysts, the average taret price for AMGN is USD 299.96 over the next 12 months. The maximum analyst target price is USD 350 while the minimum anlayst target price is USD 230.

AMGN stock's Price/Earning ratio is 23.15. Our analysis grades AMGN stock's Price / Earning ratio at C-. This means that AMGN stock's Price/Earning ratio is above 29% of the stocks in the Drug Manufacturers - General sector in the NSD exchange. Based on this AMGN may be undervalued for its sector.

The last closing price of AMGN's stock was USD 289.18.

The most recent market capitalization for AMGN is USD 154.98B.

Based on targets from 17 analysts, the average taret price for AMGN is projected at USD 299.96 over the next 12 months. This means that AMGN's stock price may go up by +3.73% over the next 12 months.

We can't find any ETFs which contains Amgen Inc's stock.

As per our most recent records Amgen Inc has 26,700 Employees.

Amgen Inc's registered address is One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799. You can get more information about it from Amgen Inc's website at https://www.amgen.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...